Navigation Links
Medicsight Announces New Marketing Partnership with INFINITT

NEW YORK, April 7, 2008 /PRNewswire-FirstCall/ -- Medicsight PLC, a subsidiary of MGT Capital Investments, Inc. (Amex: MGT), and an industry leader in the development of Computer-Aided Detection (CAD) and image analysis software which assists in the early detection and diagnosis of disease, announces a new global partnership with INFINITT, one of the world's leading medical imaging and picture archiving and communication systems (PACS) companies. Combined INFINITT-Medicsight products for the detection of colorectal cancer will be distributed using INFINITT's global network of offices in six strategic countries and partners and sales channel representatives in 20 other countries worldwide.

David Sumner, Chief Executive of Medicsight, said: "I am delighted to announce this new global partnership with INFINITT, already the PACS market leader in Korea and growing rapidly in other major markets. Strategic partnerships such as this one are a key component of our strategy to build a broad base distribution channel enabling the Company to penetrate global markets quickly and thereby move into profitability."

"This is the ideal time for INFINITT to partner with Medicsight," said Sun-Joo Lee, President and CEO of INFINITT. "The partnership will enable us to bring the next generation of INFINITT solutions combined with the CAD and image analysis solutions of Medicsight to meet the demanding needs of our global customers."

Dr. Se Hyung Kim, Assistant Professor, Department of Radiology, Seoul National University, also commented: "CT Colonography for the screening of colorectal cancer is now at the forefront of screening technologies for this potentially fatal disease. Partnerships such as that between Medicsight and INFINITT which deliver cutting edge 3D and CAD technologies to radiologists around the world are vital to increase the adoption of this very important and life saving technique."

Medicsight's ColonCAD(TM) software will be integrated into INFINITT's PACS and 3D Rapidia Virtual Colonoscopy workstations. The latter is a next- generation colorectal cancer screening tool. Integration has already commenced and a successful work-in-progress project was demonstrated at the Radiology Society of North America (RSNA) meeting in November 2007, the major radiology event of the year. Medicsight and INFINITT will work together to prepare for a 2008 global launch campaign.

About MGT Capital Investments, Inc.

MGT Capital Investments, Inc is a holding company that focuses on investments in the global healthcare information technology market. The Company has two subsidiaries, Medicsight PLC and Medicexchange PLC.

Medicsight PLC (AIM: MDST) is a leading developer of computer-aided detection (CAD) software solutions. Medicsight's CAD solutions help clinicians utilizing Computed Tomography (CT) scans to identify, measure and analyze suspicious pathology within the colon and lungs. The Medicsight CAD products are validated against one of the world's largest databases of verified CT scan data collected from leading healthcare institutions from around the world. Medicsight products allow radiologists and physicians to review scans more quickly and accurately -- saving both time and lives

Medicexchange PLC provides medical imaging professionals with a global web portal containing an online sales, jobs and information channel for diagnostic, treatment and surgery planning solutions. This combined with a variety of relevant clinical papers, training materials and content gives these professionals access to information and products that they otherwise would have difficulty accessing.

Additional information can be found at


INFINITT Co., Ltd. is one of the world's leading companies in medical imaging and information management. INFINITT, founded in 1997, develops, manufactures and markets PACS systems, 3D medical imaging workstations and imaging software that are now implemented in over 1000 medical institutions in 14 countries, making the company one of the fastest growing vendors in the global PACS industry. INFINITT is the market leader in the South Korea PACS market, and is aggressively pioneering worldwide market expansion through joint ventures in four strategic regions: Japan, China, Taiwan, and the US, with a branch office in Malaysia.

All forward-looking statements are made pursuant to the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current management expectations that involve risks and uncertainties that may result in such expectations not being realized. Potential risks and uncertainties include, but are not limited to, the risks described in company filings with the Securities and Exchange Commission.

Investor & Media enquiries:

KCSA Strategic Communications

Todd Fromer / Garth Russell

Tel: +1 212-896-1215 / 212-896-1250 /

SOURCE MGT Capital Investments, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Medicsight Welcomes U.S. Initiative to Reimburse CT Colonography for Early Detection of Colorectal Cancer
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
5. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
6. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
7. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
Post Your Comments:
(Date:11/24/2015)... CITY , Nov. 24, 2015 /PRNewswire/ - ... "Company") announced today that the remaining 11,000 post-share ... Share Purchase Warrants (the "Series B Warrants") subject ... were exercised on November 23, 2015, which will ... Shares.  After giving effect to the issuance of ...
(Date:11/24/2015)... ... , ... InSphero AG, the leading supplier of easy-to-use solutions for production, culture, ... serve as Chief Operating Officer. , Having joined InSphero in November 2013 ... was promoted to Head of InSphero Diagnostics in 2014. There she has built ...
(Date:11/24/2015)... Capricor Therapeutics, Inc. (NASDAQ: ... development and commercialization of first-in-class therapeutics, today announced that ... scheduled to present at the 2015 Piper Jaffray Healthcare ... at The Lotte New York Palace Hotel in ... . --> . ...
(Date:11/24/2015)... , November 24, 2015 , ... a European healthcare fund ... companies will work closely together in identifying European breakthrough technologies ... need. The collaboration is underpinned by a significant investment by ... is the first investment by Bristol-Myers Squibb in a European ...
Breaking Biology Technology:
(Date:11/18/2015)... York , November 18, 2015 ... Research has published a new market report titled  Gesture ... Trends, and Forecast, 2015 - 2021. According to the report, ... 2014 and is anticipated to reach US$29.1 bn by ... 2021. North America dominated ...
(Date:11/17/2015)... November 17, 2015 Paris ... 2015.  --> Paris , qui ... DERMALOG, le leader de l,innovation biométrique, a inventé ... passeports et empreintes sur la même surface de balayage. ... et l,autre pour les empreintes digitales. Désormais, un seul ...
(Date:11/17/2015)... SOUTH EASTON, Mass. , Nov. 17, 2015 /PRNewswire/ ... "Company"), a leader in the development and sale of ... to the worldwide life sciences industry, today announced it ... closing of its $5 million Private Placement (the "Offering"), ... Offering to $4,025,000.  One or more additional closings are ...
Breaking Biology News(10 mins):